Expression of HCV genotype-4 core antigen in prokaryotic E. coli system for diagnosis of HCV infection in Egypt

Bibliographic Information
Authors: Saleh E.M.; Gouda A.E.; Medhat A.M.; Ahmed H.O.; Shemis M.A.
Journal: Protein Expression and Purification
Publisher: Academic Press Inc.
Publication Date: December 2021
Volume / Issue: Volume 188
Article No.: 105965
ISSN: 10465928
DOI: 10.1016/j.pep.2021.105965
Scopus: View on Scopus
PubMed: 34461217
Document Type: Article
Authors and Affiliations
Saleh E.M., Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt; Gouda A.E., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Medhat A.M., Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt; Ahmed H.O., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Shemis M.A., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Background: Egypt has a high prevalence of hepatitis C virus (HCV) infection with 92.5% of genotype-4. Aim: This study aimed to clone and express the core gene of HCV genotype-4 for using it to develop a highly sensitive, specific, and cost-effective diagnostic assay for detecting HCV infection. Methods: Using synthetic HCV genotype-4 core gene, pET15b as E. coli expression vector, and 1 mM lactose as inducer, the HCV core protein (MW 17 kDa) was expressed in the form of inclusion bodies (IBs) that was purified and solubilized using 8 M guanidinium HCl. The recombinant core protein was in vitro refolded by a rapid dilution method for further purification using weak cation exchange liquid chromatography. The immunogenicity of the purified protein was tested by ELISA using 129 serum samples. Results: The recombinant core protein was successfully expressed and purified. The results also showed that the in-house anti-HCV core assay is accurate, specific (~96.6%), and highly sensitive (~100%) in accordance with the commercial ELISA kit. Conclusion: The sensitivity, specificity, and reproducibility of the developed assay were high and promising to be used as a screening assay for detecting HCV infection. © 2021 Elsevier Inc.
Keywords
Core protein; ELISA; HCV; Inclusion bodies; Refolding; Antibodies, Viral; Antigens, Viral; Chromatography, Ion Exchange; Cloning, Molecular; Egypt; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Gene Expression; Genetic Vectors; Genotype; Guanidine; Hepacivirus; Hepatitis C; Humans; Immune Sera; Prevalence; Protein Refolding; Recombinant Proteins; Viral Core Proteins; antiserum; nucleocapsid protein, Hepatitis C virus; recombinant protein; virus antibody; virus antigen; biosynthesis; blood; cell inclusion; chemistry; classification; enzyme linked immunosorbent assay; gene vector; genetics; human; immunology; ion exchange chromatography; isolation and purification; metabolism; molecular cloning; procedures; virology
Citation Information
Scopus Citations: 6
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
